arbekacin has been researched along with dibekacin in 247 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (8.91) | 18.7374 |
| 1990's | 94 (38.06) | 18.2507 |
| 2000's | 76 (30.77) | 29.6817 |
| 2010's | 49 (19.84) | 24.3611 |
| 2020's | 6 (2.43) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Ike, Y; Kimura, K; Kurokawa, H; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Kirikae, T; Kitao, T; Miyoshi-Akiyama, T | 1 |
| Kawakami, Y; Kobayashi, Y; Uchida, H | 1 |
| Inouye, Y; Masumi, N; Morifuji, K; Nakamura, S; Santou, T; Takesue, Y; Yokoyama, T | 1 |
| Watanabe, A | 1 |
| Irifune, A; Kaneda, A; Mitoh, Y; Shiigai, T; Shintani, S; Tanaka, H; Udono, H | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Yokota, N | 3 |
| Arakawa, M; kawashima, T; Tsukasa, H; Wada, K | 1 |
| Nitta, Y; Sunakawa, K; Yokota, T | 1 |
| Inamatsu, T | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, K; Suzuki, Y; Yokota, N | 1 |
| Kobayashi, Y | 1 |
| Hamada, M; Hattori, S; Ikeda, Y; Kondo, S; Takeuchi, T | 1 |
| Niijima, T | 1 |
| Kishi, M; Kumon, H; Mizuno, A; Nasu, Y; Ohmori, H; Tsugawa, M | 1 |
| Arakawa, S; Fujii, A; Hamada, K; Hara, S; Kamidono, S; Maeda, H; Miyazaki, S | 1 |
| Ariga, H; Tanaka, N; Yamaki, H | 1 |
| Fillastre, JP; Morin, JP; Olier, B; Thomas, N | 1 |
| Price, KE | 1 |
| Hara, K; Hayashi, T; Masuyama, Y; Oda, T; Saito, A; Shigeno, Y; Taira, K; Tomita, H; Yamaguchi, K | 1 |
| Coude du Foresto, B; Courtieu, AL; Derriennic, M; Reynaud, AE | 1 |
| Matsuhashi, Y; Yamamoto, H | 1 |
| Bernadet, P; Fillastre, JP; Humbert, G; Josse, S; Leroy, A; Moulin, B | 2 |
| Komiya, I; Shimada, N; Shinkai, S; Shomura, T; Ueda, T; Yokoshima, T | 1 |
| Fujigaki, M; Kai, F; Komiya, I; Matsumoto, T; Mitomi, N | 1 |
| Fujita, M; Nakayoshi, T; Sannomiya, F; Shinkai, S; Tomono, N | 1 |
| Fujita, M; Nakayoshi, T; Shinkai, S; Tomono, N | 1 |
| Goi, H; Hara, T; Kazuno, Y; Matsuhashi, Y; Sugano, T; Tanaka, Y; Watanabe, T; Yamamoto, H; Yokota, T | 1 |
| Kai, F; Kurebe, M; Mitsuhashi, S; Niizato, T; Okamoto, R; Yokota, M; Yoshida, T | 1 |
| Bouanchaud, DH; Rolin, O | 1 |
| Engelbart, K; Marre, R; Sack, K; Schulz, E; Stewens, J | 1 |
| Hirata, A; Matsuhisa, Y; Matsunaga, K; Nishimura, T; Tanaka, N | 1 |
| Matsunaga, K; Nishimura, T; Tanaka, N | 1 |
| Matsunaga, K; Nishimura, T; Tanaka, N; Yamaki, H | 1 |
| Tanaka, Y | 1 |
| Hamada, T; Harada, R; Hata, E; Miyamoto, H; Sakao, Y | 1 |
| Hashimoto, M; Inouye, Y; Santo, T; Sugiyama, M; Takesue, Y; Yokoyama, T | 1 |
| Hamilton-Miller, JM; Shah, S | 1 |
| Kanno, M; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T | 1 |
| Hashimoto, H; Hayashi, I; Inoue, M | 3 |
| Ida, T; Inoue, M; Nonoyama, M; Okamoto, R | 1 |
| Hayashi, I; Inoue, M | 1 |
| Matsuo, K; Uete, T | 1 |
| Hayashi, I; Ichiki, M; Ishikawa, T; Karato, A; Niida, M; Ogawa, M; Sakurai, M; Sekine, I; Shiotani, J; Yoshida, T | 1 |
| Ishizaka, S; Okai, Y | 1 |
| Nishioka, K; Tanno, Y; Wang, R | 1 |
| Kondo, S | 1 |
| Hashimoto, H | 1 |
| Hasobe, T; Ida, T; Inoue, M; Nonoyama, M; Okamoto, R; Okubo, T; Shimauchi, C | 1 |
| Fujita, K; Nagamachi, Y; Okubo, T; Suzuki, T | 1 |
| Aoki, Y | 1 |
| Ishii, T; Orikasa, Y; Takase, Y; Takayama, Y | 1 |
| Goto, S; Sugano, T; Takada, T; Takase, Y; Tsuji, A; Yamaguchi, K; Yoshida, T | 1 |
| Asaoka, H; Niizato, T; Nishiyama, S; Ohnishi, M; Saito, A | 1 |
| Araake, M; Mitomi, N; Niizato, T; Shimizu, K; Totsuka, K | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, K; Suzuki, Y; Yokota, N | 2 |
| Kanno, M; Kawabata, T; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T | 1 |
| Arakawa, K; Kono, K; Takeda, S; Tatara, I | 1 |
| Azuma, E; Nasuhara, K; Saijo, N; Saito, I; Shinohara, M; Sone, H; Takatsuka, K; Takatsuka, N; Teraoka, M; Tokita, S | 1 |
| Ichiyama, S; Shimokata, K | 1 |
| Arakawa, M; Honma, T; Hoshino, S; Miyao, H; Sato, S; Sega, H; Shimazu, Y; Tsukada, H; Wada, K; Yoshikawa, H | 1 |
| Kanno, S; Kawashima, T; Kikuchi, N; Kunitomo, F; Kuriyama, T; Mizutani, F; Nakamura, H; Shishibara, T; Watanabe, M; Yamagishi, F | 1 |
| Imai, T; Ito, A; Matsumoto, F; Odagiri, S; Sakurai, I; Sugiyama, M; Sumitomo, M; Suzuki, M; Takahashi, K; Yoshikawa, K | 1 |
| Hamazaki, H; Hasegawa, H; Horiuchi, A; Kageyama, T; Kanayama, Y; Kitani, T; Masaoka, T; Sugiyama, H; Tatsumi, N; Uchino, H | 1 |
| Arita, K; Kodama, T; Konishi, F; Kurimura, T; Kuwabara, M; Miyazawa, T; Miyoshi, N; Nakai, S; Santoh, T; Yokoyama, T | 1 |
| Goto, A; Hasegawa, S; Irokawa, M; Ishida, H; Iwata, S; Nakai, T; Otsuka, M; Sawahata, T; Shinohara, Y; Yoshizawa, Y | 1 |
| Fujioka, Y; Houjou, S; Iida-Tanaka, K; Miki, S; Nakamura, Y; Takahara, J; Takahashi, T; Tamura, T; Tanaka, T; Yamanoi, Y | 1 |
| Arakawa, K; Hattori, F; Hoshino, H; Kono, K; Minamikawa, H; Miyake, S; Sato, M; Takeda, S; Tanaka, H; Tatara, I | 1 |
| Hara, K; Hashimoto, A; Inoue, Y; Kaku, M; Koga, H; Kohno, S; Ohtsubo, T; Sugiyama, H; Taira, K; Tomono, K | 1 |
| Fujita, K; Kato, H; Nagamachi, Y; Okubo, T; Suzuki, T | 1 |
| Hori, K; Ishikawa, S; Mashita, K; Mizuno, A; Shinagawa, N; Yura, J | 1 |
| Fujimoto, M; Hirata, S; Kaji, M; Kinoshita, H; Morimoto, K; Nakatani, S; Tamate, S; Ueda, T; Yamazaki, O | 1 |
| Kasitani, M; Konishi, R; Kouno, N; Noguchi, K; Ochiai, M; Ohkouchi, N; Ohnishi, H; Shimada, K; Takifuji, K; Tanimura, H | 1 |
| Abe, T; Fujii, R; Fujita, K; Meguro, H; Mikuni, K; Sakai, T; Sakata, Y; Tajima, T; Terashima, I; Watanabe, N | 1 |
| Tsuji, A | 1 |
| Natori, H; Oizumi, K; Tanaka, K; Tokunaga, N | 1 |
| Akahane, T; Furihata, K; Furuwatari, C; Katsuyama, T; Kawakami, Y; Matsumoto, H; Okimura, Y | 1 |
| Komiya, I; Kuribayashi, T; Mitomi, N; Takata, H | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Yokota, N | 1 |
| Aoto, T; Kimura, A; Nishizawa, K; Otsuka, T | 1 |
| Fuse, H; Katayama, T; Kazama, T; Muraishi, Y; Okumura, A; Sakamoto, M; Tsuritani, S | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Suzuki, K; Suzuki, Y; Yokota, N | 2 |
| Hamada, M; Shitara, T; Takeuchi, T; Tomono, N; Tsuchiya, T; Umemura, E; Umezawa, S | 1 |
| Gomi, S; Ikeda, Y; Kondo, S; Mitsuhashi, S; Takeuchi, T; Tamura, A | 1 |
| Gomi, S; Ikeda, D; Ikeda, Y; Kondo, S; Kudo, T; Shibahara, S; Takeuchi, T; Tamura, A; Usui, T | 1 |
| Deguchi, T; Ito, Y; Kanematsu, M; Kawada, Y; Komeda, H; Okano, M; Saitoh, A; Takahashi, Y; Tokuyama, H; Yamada, S | 1 |
| Matsuno, T; Shitara, T; Tsuchiya, T; Umemura, E | 1 |
| Hotta, K; Ikeda, Y; Ishikawa, J; Kondo, S; Mizuno, S; Ogata, T; Sunada, A; Zhu, CB | 1 |
| Deguchi, K; Fukumoto, T; Ishihara, R; Ishii, Y; Matsumoto, Y; Nakane, Y; Nakazawa, A; Nishinari, C; Suzuki, Y | 1 |
| Kubota, T; Matsui, K; Ohashi, K; Watanabe, T | 1 |
| Fujita, T; Fukai, H; Kayama, T; Nakai, O; Sato, I; Sobue, H | 1 |
| Fujita, J; Hojo, S; Ichiyama, S; Kawanishi, K; Miyawaki, H; Negayama, K; Obayashi, Y; Takahara, J; Takashima, C; Tanabe, T; Yamaji, Y | 1 |
| Hanaki, H; Hiramatsu, K; Ino, T; Oguri, T; Tenover, FC; Yabuta, K | 1 |
| Itokazu, M; Kato, N; Ohno, T; Tanemori, T; Wada, E; Watanabe, K | 1 |
| Kato, Y; Kumagai, T; Matsuoka, T; Pant, B; Sugiyama, M | 1 |
| Higurashi, Y; Nakahara, K; Okuzumi, K; Yoneyama, A | 1 |
| Fujimura, S; Hisamichi, K; Mikami, T; Nukiwa, T; Takahashi, H; Tokue, Y; Watanabe, A | 1 |
| Kohno, J; Takahashi, Y; Tsuchiya, T | 1 |
| Koizumi, A; Konishi, M; Maeda, K; Masutani, T; Mikasa, K; Mori, K; Narita, N; Sano, R; Sawaki, M; Tsujimoto, M | 1 |
| Hotta, K; Ikeda, Y; Ishikawa, J; Kondo, S; Mizuno, S; Sunada, A | 1 |
| Hiramatsu, K; Inaba, Y | 1 |
| Fujimura, S; Nukiwa, T; Takahashi, H; Tokue, Y; Watanabe, A | 1 |
| Chow, JW; Chow, L; Kariyama, R; Kumon, H; Tabata, M; Takata, T; Zervos, MJ | 1 |
| Fukayama, M | 1 |
| Itokazu, M; Kumazawa, S; Matsunaga, T; Oka, M | 1 |
| Hashimoto, Y; Inui, K; Kokuryo, T; Nakamura, T; Okuda, M | 1 |
| Arakawa, Y; Hotta, K; Ike, Y; Ishii, R; Ishikawa, J; Kira, K; Saitoh, F | 1 |
| Endo, K | 1 |
| Hotta, K; Ikeda, Y; Ishikawa, J; Kondo, S; Sunada, A; Zhu, CB | 1 |
| Fukuhara, J; Homma, S; Kouda, M; Takeuchi, M; Tamura, K; Udagawa, I | 2 |
| Arakawa, K; Kono, K; Takeda, S; Yasunaka, K | 1 |
| Chow, JW; Kariyama, R; Kumon, H; You, I; Zervos, MJ | 1 |
| Aihara, Y; Fukamachi, K; Hori, T; Imamura, T; Kasuya, H; Kawashima, A; Kikuchi, K; Ochiai, T; Shiseki, M; Tozuka, K; Yamaguchi, K | 1 |
| Akins, RL; Rybak, MJ | 1 |
| Ishikawa, S; Koyano, T; Morishita, Y; Noda, D; Ooki, S; Shimizu, H; Takahashi, T | 1 |
| Chow, JW; Donabedian, SM; Kak, V; Kariyama, R; Kumon, H; Zervos, MJ | 1 |
| Hotta, K; Ishikawa, J; Tsuchizaki, N | 1 |
| Chow, JW; Kak, V; Kariyama, R; Kumon, H; You, I; Zervos, MJ | 1 |
| Abe, T; Fujimura, S; Gomi, K; Kobayashi, T; Nukiwa, T; Takahashi, H; Tokue, Y; Watanabe, A | 1 |
| Araake, M; Hara, T; Miyata, A; Ogawa, H; Tani, M | 1 |
| Cordeiro, JC; Miranda, EA; Reis, AO; Sader, HS | 1 |
| Araake, M; Hanaki, H; Hiramatsu, K; Miyata, A; Ogawa, H | 1 |
| Hashimoto, Y; Kato, M; Liu, M | 1 |
| Hanaki, H | 1 |
| Chen, G; Fukuchi, K; Gomi, K; Kubo, S; Takagi, Y; Wakuta, R; Yasuhara, T | 1 |
| Ishii, Y; Tanaka, A | 1 |
| Bhuyian, A; McElgunn, CJ; Sugiyama, M; Zahurul, M | 1 |
| Akaki, T; Dekio, S | 1 |
| Fujita, A; Inagaki, K; Inatomi, T; Kinoshita, S; Koizumi, N; Sano, Y; Sotozono, C | 1 |
| Higashi, K; Itoman, M; Miyabe, M; Naruse, K; Takahira, N; Uchiyama, K | 1 |
| Hijioka, S; Nakata, R; Nishimura, T; Sugita, K; Yoshinami, Y | 1 |
| Matsuzaki, T; Suzuki, K; Tanikawa, K | 1 |
| Araake, M; Ogawa, H; Shimizu, M; Tabata, M | 1 |
| Kawamura, Y; Kizawa, K; Miyazaki, M; Nagai, A; Nagasawa, M; Ogake, N; Sanzen, T | 1 |
| Arashiki, Y; Hatakeyama, Y; Hosoi, K; Kobayashi, M; Oda, M; Oka, A; Saitoh, H | 1 |
| Suzuki, K | 1 |
| Kobayashi, M; Kumagai, T; Kuwabara, M; Matsuo, H; Sugiyama, M | 1 |
| Hirano, M; Katayama, S; Kawada, K; Momose, Y; Nishizawa, K; Takehira, R; Yamamura, S | 3 |
| Choi, JH; Choi, SM; Chun, HS; Kang, MW; Lee, DG; Shin, WS; Yim, DS; Yoo, JH | 1 |
| Arakawa, Y; Doi, Y; Kato, H; Shibata, N; Shibayama, K; Wachino, J; Yagi, T; Yamane, K; Yokoyama, K | 1 |
| Kimura, T; Kubo, H; Matsuura, N; Shimada, S; Sunakawa, K; Yago, K | 1 |
| Endo, K; Fukuda, M; Hashikita, G; Itabashi, A; Maesaki, S; Tominaga, K; Yamazaki, T | 1 |
| Shiotani, J; Takehana, K | 1 |
| Hikida, M; Kawabata, T; Maebashi, K; Niida, M; Sakakibara, S; Takata, T | 1 |
| LaPlante, KL; Rybak, MJ | 1 |
| Morikawa, K; Nonaka, M; Torii, I; Yoshikawa, Y | 2 |
| Hotta, K; Ikeda, Y; Ishikawa, J; Ishino, K | 1 |
| Ebisu, R; Minowa, H; Takahashi, Y; Uchida, Y; Yoshida, K; Yoshioka, A | 1 |
| Hanaki, H; Matui, H; Oishi, T; Sunakawa, K; Uehara, K; Yamaguchi, Y; Yanagisawa, C | 1 |
| Arakawa, Y; Doi, Y; Kurokawa, H; Wachino, J; Yamane, K | 1 |
| Hayashi, H; Matsumoto, Y; Matsuzaki, T; Saito, A; Shimizu, M | 1 |
| Hatano, T; Kariyama, R; Kuroda, T; Nagoshi, C; Shiota, S; Tsuchiya, T; Yoshida, T | 1 |
| Chin, JN; LaPlante, KL; Leuthner, KD; Rybak, MJ | 1 |
| Heo, ST; Ki, HK; Kiem, S; Ko, KS; Lee, JY; Moon, CS; Oh, WS; Peck, KR; Song, JH | 1 |
| Hotta, K; Ishikawa, J; Ishino, K; Nakajima, M; Saito, F; Tsuchizaki, N | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
| Aikawa, N; Kaku, M; Morita, K; Sato, R; Shimizu, K; Tanigawara, Y | 1 |
| Aikawa, N; Kaku, M; Sato, R; Shimizu, K; Tanigawara, Y | 1 |
| Hotta, K; Ishikawa, J; Ishino, K; Tsuchizaki, N | 1 |
| Udou, T | 1 |
| Sunakawa, K | 1 |
| Akama, H; Barada, K; Hanaki, H; Ikeda, S; Inamatsu, T; Nakae, T; Sunakawa, K; Yamaguchi, Y | 1 |
| Akiyama, Y; Hiraiwa, Y; Ikeda, D; Maebashi, K; Minowa, N; Usui, T | 2 |
| Kimura, T; Kokubun, H; Yago, K | 1 |
| Arakawa, Y; Ishikawa, S; Kai, K; Kato, H; Kimura, K; Konda, T; Ozawa, Y; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Hayashi, I; Ida, T; Kato, Y; Maebashi, K; Sakurai, M; Shiotani, J; Suzuki, T | 1 |
| Chong, Y; Kim, CK; Lee, H; Lee, J; Lee, K; Roh, KH; Yong, D; Yum, JH | 1 |
| Aoyama, T; Hayashi, H; Matsumoto, Y; Matsuzaki, T; Saito, A | 1 |
| Fujii, K; Murakami, S; Nagai, J; Takano, M; Yumoto, R | 1 |
| Kim, JH; Lah, HO; Yim, DS | 1 |
| Araki, H; Inoue, T; Murase, M; Nishimiya, T; Otsuka, T; Suemaru, K; Tanaka, A | 1 |
| Ariyoshi, N; Hasegawa, A; Hashimoto, N; Igari, H; Kitada, M; Nakamura, H; Nakamura, Y; Nakasa, H; Nakazawa, K; Nomura, F; Sato, T; Watanabe, A; Watanabe, M; Yokoyama, I | 1 |
| Aibiki, M; Fukuoka, N | 1 |
| Aoyama, T; Hayashi, H; Iwahori, T; Kawai, M; Matsumoto, Y; Matsuzaki, T; Mizuno, Y; Saito, A | 1 |
| Abe, Y; Akiyama, O; Ito, M; Okura, H; Suga, Y; Tsutsumi, S; Yasumoto, Y | 1 |
| Fujii, K; Nagai, J; Sawada, T; Takano, M; Yumoto, R | 1 |
| Fukushima, T; Hirose, Y; Iwao, H; Masaki, Y; Miki, M; Nakazima, A; Sakai, T; Sawaki, T; Tanaka, M; Umehara, H | 1 |
| Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H | 1 |
| Ikawa, K; Ikeda, K; Morikawa, N; Suyama, H; Yamanoue, T | 1 |
| Adachi, H; Akamatsu, Y; Hashizume, H; Igarashi, M; Nishimura, Y | 1 |
| Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ | 1 |
| Higuchi, W; Ishii, S; Matsunaga, M; Sato, T; Shi, D; Takano, T; Tanaka, K; Yabe, S; Yamamoto, T; Yamazaki, H | 1 |
| Hattori, T; Kazato, Y; Mori, R; Shimada, H; Yamamoto, A; Yuzawa, M | 1 |
| Furugaki, K; Oyama, M; Yoshida, J | 1 |
| Kinoshita, D | 1 |
| Hamada, Y; Koyama, I; Kuroyama, M; Sunakawa, K; Tamura, K; Yago, K | 1 |
| Eriguchi, Y; Harada, Y; Kadowaki, M; Miyake, N; Nagasaki, Y; Sato, Y; Shimono, N; Uchida, Y | 1 |
| Hwang, JH; Kim, JS; Lee, CS; Lee, JH; Moon, MK; Won, KS | 1 |
| Araoka, H; Baba, M; Ishii, Y; Mitsuda, T; Mori, S; Moriya, K; Nakamori, Y; Oguri, T; Ohmagari, N; Oishi, T; Okuzumi, K; Tateda, K; Yamaguchi, K; Yoneyama, A | 1 |
| Fukuda, Y; Hashiguchi, K; Imamura, Y; Inoue, Y; Izumikawa, K; Kakeya, H; Kobayashi, T; Kohno, S; Kondo, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Yamamoto, Y; Yanagihara, K | 1 |
| Miyake, N; Nagasaki, Y; Shimono, N; To, K | 1 |
| Miyoshi, K; Miyoshi, S; Oto, T; Soh, J; Sugimoto, S; Toyooka, S; Ueno, T; Yamane, M | 1 |
| Niki, Y | 1 |
| Hanaki, H; Ishii, T; Iwatsuki, M; Masuma, R; Matsui, H; Nonaka, K; Omura, S; Shiomi, K; Suga, T; Yamamoto, T | 1 |
| Kirikae, T; Miyoshi-Akiyama, T; Shimada, K; Shimojima, M; Tada, T | 1 |
| Hayashi, M; Ikawa, K; Imanishi, T; Kondo, M; Morikawa, N; Nishii, M; Ooi, K; Wakabayashi, H; Yamada, S | 1 |
| Hamada, Y; Koyama, I; Kuroyama, M; Seki, M; Sunakawa, K; Tamura, K; Yago, K | 1 |
| Kawasumi, N; Kimura, M; Mikamo, H; Yamagishi, Y | 1 |
| Akiyama, N; Arai, T; Hanaki, H; Higashihara, M; Ichiwata, T; Ikegami, K; Kimura, T; Kobayashi, M; Matsumoto, T; Miyao, N; Nemoto, M; Oda, S; Ohyashiki, K; Otsuka, Y; Soma, K; Sunakawa, K; Suzuki, Y; Totsuka, K; Yokota, H; Yoshida, M; Yukioka, T | 1 |
| Breaud, AR; Clarke, W; Emezienna, N; Henemyre-Harris, CL; Schools, S | 1 |
| Hori, S; Sunakawa, K | 1 |
| Fudaba, Y; Hattori, M; Hirakawa, H; Hisatsune, J; Kato, F; Kayama, S; Oshima, K; Sugai, M; Yamaguchi, T | 1 |
| Hamada, Y; Igarashi, M; Kasahara, K; Kimura, M; Kimura, T; Kobayashi, M; Matsumoto, K; Mikamo, H; Mochizuki, T; Nishi, Y; Ohmagari, N; Okada, K; Seki, M; Takahashi, Y; Takakura, S; Takesue, Y; Tanigawara, Y; Tokimatsu, I | 1 |
| Akashi, K; Chong, Y; Harada, Y; Kadowaki, M; Miyake, N; Shimoda, S; Shimono, N; Uchida, Y | 1 |
| Asami, T; Betsuyaku, T; Fujiwara, H; Funatsu, Y; Hasegawa, N; Iketani, O; Ishii, M; Iwata, S; Kamata, H; Kimizuka, Y; Namkoong, H; Ogata, H; Tasaka, S | 1 |
| Anandan, S; Balaji, V; Falagas, ME; Rajenderan, S; Sahni, RD; Tansarli, GS | 1 |
| Dahal, RK; Kirikae, T; Mishra, SK; Miyoshi-Akiyama, T; Ohara, H; Pokhrel, BM; Shimada, K; Tada, T | 1 |
| Hara, T; Ikawa, K; Joichi, Y; Koba, Y; Morikawa, N; Nagaoka, R; Ohge, H; Onodera, M; Yokozaki, M | 1 |
| Hamada, Y; Hirai, J; Mikamo, H; Suematsu, H; Yamagishi, Y | 1 |
| Farrell, DJ; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Akamatsu, Y; Kobayashi, Y; Kurihara, T; Miyake, T; Sasaki, K; Takahashi, Y; Yamashita, Y | 1 |
| Chung, KM; Hwang, JH; Kim, JS; Lee, CS; Lee, EJ; Lee, JH; Moon, MK; Won, KS; Yoon, YJ | 1 |
| Sato, K | 1 |
| Chahine, S; Hinkle, M; Kwak, YI; Lesho, E; Maybank, R; McGann, P; Okafor, D; Ong, AC; Wilson, K; Zapor, M | 1 |
| Akamatsu, N; Hasegawa, H; Kawakami, K; Kimura, Y; Kosai, K; Matsuda, J; Matsuo, H; Morinaga, Y; Uno, N; Yamaryo, T; Yanagihara, K | 1 |
| Hatta, Y; Hirabayashi, Y; Hojo, A; Iriyama, N; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kurita, D; Kusuda, M; Miura, K; Nakagawa, M; Ohtake, S; Sakagami, M; Takahashi, H; Takei, M; Uchino, Y | 1 |
| Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
| Takeshima, Y | 1 |
| Hagihara, M; Hamada, Y; Hirai, J; Kato, H; Koizumi, Y; Matsuura, K; Mikamo, H; Nishiyama, N; Sakanashi, D; Suematsu, H; Yamagishi, Y | 1 |
| Asami, Y; Hanaki, H; Iwamoto, S; Iwatsuki, M; Masuma, R; Matsui, H; Nonaka, K; Ōmura, S; Onodera, H; Shiina, M; Shiomi, K; Suga, T; Yamamoto, T | 1 |
| Hasegawa, H; Izumikawa, K; Kaku, N; Kosai, K; Miyazaki, T; Morinaga, Y; Mukae, H; Takeda, K; Uno, N; Yanagihara, K | 1 |
| Cho, H; Chung, NG; Han, SB; Park, KG; Park, YJ | 1 |
| Fujita, J; Kirikae, T; Nakasone, I; Shimada, K; Sonozaki, T; Tada, T; Uechi, K | 1 |
| Hotta, K; Kondo, S | 1 |
| Chen, ZH; Li, C; Li, G; Qiao, RZ; Wang, F; Wang, S; Zhang, J; Zhou, H | 1 |
| Ambrose, PG; Bhavnani, SM; Kondo, K; Koresawa, T; Lakota, EA; Rubino, CM; Sato, N | 1 |
| Agarwal, R; Agrawal, RP; Basu, I; Bhalla, H; Bs, M; Das, C; Deb, AK; Dube, A; Kurlekar, U; Padhye, D; Pawar, R; Shahavi, V; Singh, RM; Srivastava, A; Srivastava, P | 1 |
| Chuma, M; Hamada, T; Hatta, Y; Imai, T; Iriyama, N; Iwabuchi, S; Kimura, T; Matsumoto, C; Miura, K; Nakagawa, M; Nakayama, T; Suzuki, S; Takahashi, H; Takei, M; Tochikura, N; Uchino, Y | 1 |
| Panchal, G; Pandit, R; Sharma, A; Trailokya, A | 1 |
| Fujii, S; Mayumi, T; Oda, K; Takesue, Y; Yamamoto, T | 1 |
| Albano, M; Fleischmann, WA; Greenwood-Quaintance, KE; Patel, R | 1 |
| Mandava, CS; Parajuli, NP; Pavlov, MY; Sanyal, S | 1 |
| Goto, R; Inose, R; Ishikane, M; Ito, S; Koizumi, R; Kusama, Y; Muraki, Y; Ohmagari, N; Ono, A | 1 |
| Adams, E; Chen, D; Chen, Z; Dai, J; Geng, Y; Tang, S; Yuan, Y; Zhu, X | 1 |
16 review(s) available for arbekacin and dibekacin
| Article | Year |
|---|---|
[New antimicrobial agent series XL: arbekacin].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Humans; In Vitro Techniques; Methicillin Resistance; Mice; Staphylococcal Infections; Staphylococcus aureus | 1991 |
The potential for discovery and development of improved aminoglycosides.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Lethal Dose 50; Mice; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1986 |
[Revaluation of current antimicrobials. Series 17: Arbekacin sulfate].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Design; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1994 |
[Drug resistance of methicillin-resistant Staphylococcus aureus (MRSA) in Japan until 1993].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Japan; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Gram-positive cocci (include MRSA)].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1994 |
[Treatment of cancer and counter-measures for MRSA infections].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Cross Infection; Dibekacin; Disinfection; Female; Humans; Leukemia; Lymphoma; Male; Methicillin Resistance; Middle Aged; Patient Isolation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; Humans; Japan; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1998 |
[Methicillin resistant Staphylococcus aureus infection].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
[MRSA septicemia caused by an infected pacemaker lead: a case report with a review of Japanese literatures].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cardiopulmonary Bypass; Dibekacin; Drug Therapy, Combination; Female; Humans; Methicillin Resistance; Middle Aged; Minocycline; Pacemaker, Artificial; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2000 |
[MRSA].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Proteins; Bacterial Toxins; Dibekacin; Enterotoxins; Gentian Violet; Humans; Immunoglobulins, Intravenous; Methicillin Resistance; Repressor Proteins; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Teicoplanin; Vancomycin | 2001 |
[Appropriate usage of antibiotics by therapeutic drug monitoring].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Body Weight; Dibekacin; Drug Administration Schedule; Drug Monitoring; Extracellular Fluid; Humans; Infant, Newborn; Kidney; Patient Care Team; Renal Dialysis; Renal Insufficiency; Teicoplanin; Vancomycin | 2007 |
[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
[Genetic Diagnosis and Molecular Therapies for Duchenne Muscular Dystrophy].
Topics: Animals; Codon, Nonsense; Dibekacin; Dystrophin; Exons; Gentamicins; Humans; Mice; Molecular Targeted Therapy; Muscular Dystrophy, Duchenne; Oligonucleotides, Antisense; Pathology, Molecular; Prostaglandin D2 | 2015 |
Kanamycin and its derivative, arbekacin: significance and impact.
Topics: Animals; Anti-Bacterial Agents; Dibekacin; Humans; Kanamycin; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2018 |
Evaluation of once-daily dosing and target concentrations in therapeutic drug monitoring for arbekacin: A meta-analysis.
Topics: Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Humans; Japan; Methicillin-Resistant Staphylococcus aureus | 2021 |
26 trial(s) available for arbekacin and dibekacin
| Article | Year |
|---|---|
[Comparative clinical trial of HBK and amikacin (AMK) in the treatment of respiratory infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Dibekacin; Double-Blind Method; Female; Humans; Kanamycin; Male; Middle Aged; Respiratory Tract Infections | 1987 |
Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections.
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Female; Humans; Japan; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections | 1994 |
[Laboratory and clinical studies on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Methicillin Resistance; Middle Aged; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1994 |
[Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Humans; Kidney; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Evaluation of once-daily administration of arbekacin. Experimental study and determination of pharmacokinetic properties in man].
Topics: Adult; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Administration Schedule; Guinea Pigs; Humans; Infusions, Intravenous; Kidney; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Coagulase; Dibekacin; Female; Humans; Japan; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical efficacy of arbekacin on MRSA infections].
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kidney; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Clinical efficacy of arbekacin on MRSA pneumonia].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Kidney; Liver; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcus aureus | 1994 |
[An evaluation study on arbekacin for MRSA-infectious diseases including pneumonia, septicemia and others].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Dibekacin; Drug Therapy, Combination; Female; Humans; Kidney; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical efficacy of arbekacin on MRSA infections with hematopoietic disorders. The Hanshin Study Group of Hematopoietic Disorders and Infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Humans; Kidney; Leukemia; Lymphoma; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Efficacy of combination therapy against MRSA in Ibaraki Prefecture].
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Child; Child, Preschool; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infant; Japan; Lactams; Male; Methicillin Resistance; Middle Aged; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Staggered intensive chemotherapy using arbekacin, fosfomycin and ceftazidime on polymicrobial infections involving MRSA].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Dibekacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cilastatin; Dibekacin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical studies of arbekacin sulfate in the pediatric field].
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Dibekacin; Female; Humans; Infant; Infant, Newborn; Male; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 1994 |
Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bayes Theorem; Body Weight; Creatinine; Dibekacin; Female; Gestational Age; Glomerular Filtration Rate; Humans; Infant, Newborn; Male; Models, Biological; Population; Thienamycins; Vancomycin | 2004 |
Artificial neural network modeling to predict the plasma concentration of aminoglycosides in burn patients.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Burns; Dibekacin; Female; Fluorescence Polarization Immunoassay; Humans; Infusions, Intravenous; Linear Models; Logistic Models; Male; Middle Aged; Neural Networks, Computer | 2004 |
Factors influencing neonatal therapeutic effect of anti-MRSA drugs.
Topics: Alanine Transaminase; Albumins; Aminoglycosides; Anti-Bacterial Agents; Blood Glucose; Blood Urea Nitrogen; C-Reactive Protein; Creatinine; Dibekacin; Drug Monitoring; Humans; Infant; Infant, Newborn; Logistic Models; Methicillin Resistance; Odds Ratio; Platelet Count; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin | 2005 |
Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Child; Dibekacin; Drug Monitoring; Female; Humans; Kidney Diseases; Kidney Function Tests; Logistic Models; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Risk; Staphylococcal Infections; Staphylococcus aureus | 2006 |
Recommended dose of arbekacin, an aminoglycoside against methicillin-resistant Staphylococcus aureus, does not achieve desired serum concentration in critically ill patients with lowered creatinine clearance.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Creatinine; Critical Illness; Data Interpretation, Statistical; Dibekacin; Dose-Response Relationship, Drug; Female; Fluorescence Polarization Immunoassay; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Tissue Distribution | 2008 |
The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Sepsis; Staphylococcal Infections; Treatment Outcome | 2012 |
[Safety and pharmacokinetics of 400 and 600 mg arbekacin sulfate to healthy male volunteers].
Topics: Adult; Anti-Infective Agents; Dibekacin; Humans; Male; Young Adult | 2013 |
Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus.
Topics: Adult; Aged; Anti-Bacterial Agents; Chronic Disease; Dibekacin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Otitis Media, Suppurative; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.
Topics: Adult; Aged; Anti-Infective Agents; beta-Lactams; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Treatment Outcome | 2016 |
Population Pharmacokinetic Analyses for Arbekacin after Administration of ME1100 Inhalation Solution.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Dibekacin; Female; Humans; Male; Middle Aged; Models, Biological; Nebulizers and Vaporizers; Pharmaceutical Solutions; Young Adult | 2019 |
A Multicentre, Open label, Randomized, Comparative, Parallel Group, Active-controlled, Phase III Clinical Trial to Evaluate Safety and Efficacy of Arbekacin Sulphate Injection versus Vancomycin Injection in Patients Diagnosed with MRSA Infection.
Topics: Anti-Bacterial Agents; Dibekacin; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2018 |
205 other study(ies) available for arbekacin and dibekacin
| Article | Year |
|---|---|
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
Topics: Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Methyltransferases; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Plasmids; Protein Binding; Ribosome Subunits, Small; RNA, Ribosomal, 16S; Sequence Homology, Amino Acid | 2007 |
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
Synergy with aztreonam and arbekacin or tobramycin against Pseudomonas aeruginosa isolated from blood.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Dibekacin; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1992 |
Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. II. Isolation of arbekacin-resistant strain.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Methicillin Resistance; Phenotype; Staphylococcus aureus | 1992 |
[Respiratory tract infections in the elderly, advances and limitations in the diagnosis and treatment].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cytomegalovirus Infections; Dibekacin; Erythromycin; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin | 1992 |
Iatrogenic acute spinal epidural abscess with septic meningitis: MR findings.
Topics: Abscess; Acyclovir; Aged; Aminoglycosides; Anesthesia, Epidural; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Epidural Space; Female; Herpes Zoster; Humans; Iatrogenic Disease; Imipenem; Magnetic Resonance Imaging; Meningitis, Bacterial; Myelography; Neuralgia; Palliative Care; Spinal Diseases; Staphylococcal Infections | 1992 |
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Dibekacin; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Fosfomycin; Methicillin Resistance; Staphylococcus aureus; Ticarcillin | 1992 |
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. II. The combined effect of arbekacin with imipenem or cefminox].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephamycins; Dibekacin; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Imipenem; Methicillin Resistance; Staphylococcus aureus | 1992 |
[Septicemia caused by MRSA].
Topics: Aminoglycosides; Anti-Bacterial Agents; Catheterization; Dibekacin; Equipment Contamination; Humans; Methicillin Resistance; Prognosis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
[MRSA infections in neonates and premature infants].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Dibekacin; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
[Chemotherapy of MRSA infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Combinations; Drug Therapy, Combination; Fosfomycin; Humans; Imipenem; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Vancomycin | 1992 |
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Ceftizoxime; Dibekacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Methicillin Resistance; Staphylococcus aureus | 1992 |
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefmetazole; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Methicillin Resistance; Staphylococcus aureus | 1992 |
[Vancomycin and arbekacin, drugs of treatment for MRSA infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
[Susceptibility of methicillin-resistant Staphylococcus aureus to various antibiotics. Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Kanamycin; Kanamycin Kinase; Methicillin Resistance; Nucleotidyltransferases; Phosphotransferases; Staphylococcus aureus; Streptomycin | 1991 |
[Pharmacokinetics of arbekacin in healthy volunteers and patients with renal insufficiency].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Creatinine; Dibekacin; Humans; Kanamycin; Kidney Diseases; Kidney Function Tests; Reference Values | 1989 |
[Clinical study of aminoglycosides on renal dysfunction--pharmacokinetics of arbekacin and its elimination effects by hemodialysis and adsorption with charcoal].
Topics: Adsorption; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Charcoal; Dibekacin; Female; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Renal Dialysis | 1989 |
Inhibition of SV40 DNA replication in vitro by 1-N-acyl-3"-N-(trifluoroacetyl) kanamycin.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Antiviral Agents; Aphidicolin; Deoxycytidine Monophosphate; Dibekacin; Diterpenes; DNA Replication; DNA, Viral; Haplorhini; Hygromycin B; Kanamycin; Nalidixic Acid; Novobiocin; Simian virus 40; Spectrophotometry; Streptomycin | 1986 |
[Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Female; Gentamicins; Kanamycin; Kidney Cortex; Kidney Diseases; Netilmicin; Rats; Rats, Inbred Strains | 1988 |
[Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1988 |
[The enzymatic mechanisms of resistance to aminoglycoside antibiotics in methicillin-cephem-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Methicillin; Staphylococcus aureus | 1988 |
[Pharmacokinetics of habekacin in patients with chronic renal insufficiency].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Half-Life; Humans; Infusions, Intravenous; Injections, Intramuscular; Kanamycin; Kidney Failure, Chronic; Renal Dialysis | 1987 |
A rapid enzyme immunoassay for measurement of HBK in blood.
Topics: Aminoglycosides; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Cross Reactions; Dibekacin; Humans; Immunoenzyme Techniques; Microchemistry; Serum Albumin, Bovine | 1986 |
[Absorption, distribution, and excretion of arbekacin after intravenous and intramuscular administration in rats].
Topics: Absorption; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Half-Life; Infusions, Intravenous; Injections, Intramuscular; Kanamycin; Kinetics; Male; Models, Biological; Rats; Rats, Inbred Strains; Tissue Distribution | 1987 |
[Pharmacokinetics of arbekacin in dogs. I. Serum concentration and urinary excretion].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Dogs; Female; Half-Life; Infusions, Intravenous; Injections, Intramuscular; Kanamycin; Kinetics | 1987 |
[Pharmacokinetics of arbekacin in dogs. II. The distribution of arbekacin in tissues].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Dogs; Female; Injections, Intramuscular; Injections, Intravenous; Kanamycin; Kinetics; Tissue Distribution | 1987 |
Pharmacokinetics of habekacin in patients with renal insufficiency.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Kanamycin; Kidney Failure, Chronic; Kinetics; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Uremia | 1987 |
[Antibacterial activities of arbekacin, a new aminoglycoside antibiotic, against methicillin-cephem-resistant Staphylococcus aureus].
Topics: Abscess; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Dibekacin; Kanamycin; Male; Methicillin; Mice; Penicillin Resistance; Skin Diseases; Staphylococcus aureus | 1987 |
Antibacterial activity and ototoxicity in guinea pigs, and nephrotoxicity in rats of arbekacin.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Dibekacin; Drug Resistance, Microbial; Ear, Inner; Guinea Pigs; Injections, Intramuscular; Kanamycin; Kidney; Male; Rats; Rats, Inbred Strains; Reflex; Structure-Activity Relationship | 1986 |
Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Enterobacteriaceae Infections; Female; Gentamicins; Kanamycin; Male; Mice; Microbial Sensitivity Tests; Sepsis; Tobramycin | 1986 |
Habekacin: nephrotoxicity, pharmacokinetics and prophylactic efficacy in rats.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Escherichia coli Infections; Female; Kidney; Pyelonephritis; Rats | 1985 |
Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic.
Topics: Aminoglycosides; Anti-Bacterial Agents; Codon; Dibekacin; Escherichia coli; Peptide Biosynthesis; Ribosomes; RNA, Transfer, Amino Acyl; Translocation, Genetic | 1983 |
Bacterial uptake of habekacin, a novel aminoglycoside antibiotic.
Topics: 2,4-Dinitrophenol; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Dibekacin; Dinitrophenols; Escherichia coli; Ribosomes; Tritium | 1984 |
Inhibition of initiation of DNA synthesis by aminoglycoside antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; DNA, Bacterial; Escherichia coli; Mutation; Temperature | 1984 |
Effects of habekacin, a novel aminoglycoside antibiotic, on experimental corneal ulceration due to Pseudomonas aeruginosa.
Topics: Administration, Topical; Aminoglycosides; Animals; Anti-Bacterial Agents; Corneal Ulcer; Dibekacin; Injections, Intramuscular; Keratitis; Male; Mice; Pseudomonas Infections | 1981 |
[Combination therapy with arbekacin and fosfomycin against postoperative severe mixed-pneumonia of MRSA in primary lung cancer patients].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Immunocompromised Host; Lactams; Lung Neoplasms; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Postoperative Complications; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1995 |
Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Bleomycin; Dibekacin; Drug Interactions; Drug Resistance, Microbial; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1994 |
Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Kanamycin; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1995 |
[In vitro studies on the combined effects of arbekacin and fosfomycin on methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Methicillin Resistance; Microscopy, Electron; Staphylococcus aureus | 1995 |
Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Coagulase; Dibekacin; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Gentamicins; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 1994 |
[Clinical laboratory approach to evaluate administration dose of arbekacin. Reevaluation of in vitro MIC break points in the disk susceptibility test].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Dibekacin; False Negative Reactions; False Positive Reactions; Humans; Microbial Sensitivity Tests | 1994 |
A possible immunomodulating activity of arbekacin (ABK), a newly synthesized antibiotic against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Adjuvants, Immunologic; Aminoglycosides; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody Formation; Dibekacin; Erythrocytes; Free Radicals; In Vitro Techniques; Interleukin-1; Luminescent Measurements; Macrophages, Peritoneal; Male; Methicillin Resistance; Mice; Mice, Inbred DBA; Phagocytosis; Sheep; Spleen; Staphylococcus aureus | 1994 |
[A study on the resistance of methicillin resistant Staphylococcus aureus to antimicrobial agents].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Coagulase; Dibekacin; Drug Resistance, Microbial; Methicillin Resistance; Staphylococcus aureus; Vancomycin | 1994 |
[Special issue: Current state of MRSA infections and practical chemotherapy with arbekacin].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Questionnaires regarding MRSA in Japan].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Humans; Japan; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Surveys and Questionnaires | 1994 |
[Genomic DNA fingerprinting of arbekacin-resistant MRSA by pulsed-field gel electrophoresis].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Genome, Bacterial; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Genes, Bacterial; Gentamicins; Methicillin Resistance; Mutation; Phosphotransferases; Staphylococcus aureus | 1994 |
Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Colony Count, Microbial; Dibekacin; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1994 |
[Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Dose-Response Relationship, Drug; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 1994 |
[Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Computer Simulation; Dibekacin; Gentamicins; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[A study on nephrotoxicity of arbekacin and vancomycin in rats].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Kidney; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution; Vancomycin | 1994 |
[Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus | 1994 |
[Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cephalosporins; Cilastatin; Dibekacin; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1994 |
In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Ceftizoxime; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1994 |
[Clinical analysis of MRSA pneumonia. Niigata Research Group of MRSA.ABK].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Humans; Japan; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 1994 |
[Clinical efficacy of arbekacin in deep MRSA infection. Including follow-up study after the termination of chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cilastatin; Dibekacin; Female; Follow-Up Studies; Humans; Imipenem; Kidney; Male; Methicillin Resistance; Middle Aged; Minocycline; Recurrence; Staphylococcal Infections; Staphylococcus aureus | 1994 |
Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Superinfection | 1994 |
[MRSA infections in surgery].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Minocycline; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cilastatin; Dibekacin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 1994 |
[Clinical effect of arbekacin on MRSA infections after gastrointestinal surgery].
Topics: Administration, Inhalation; Administration, Topical; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Evaluation; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 1994 |
In vitro activity of arbekacin against clinical isolates of methicillin-resistant Staphylococcus aureus in a hospital.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 1994 |
Toxicokinetic approach for evaluating respiratory depression effect of aminoglycoside antibiotics: species differences in drug susceptibility.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Dogs; Female; Infusions, Intravenous; Male; Mice; Mice, Inbred Strains; Rabbits; Rats; Rats, Sprague-Dawley; Respiratory Insufficiency; Species Specificity | 1993 |
[Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Child; Dibekacin; Humans; Kanamycin Resistance; Methicillin Resistance; Pneumonia; Respiratory System; Staphylococcal Infections; Staphylococcus aureus | 1993 |
[Susceptibility to arbekacin in Pseudomonas aeruginosa isolated from clinical specimens].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1993 |
[Clinical studies on methicillin-resistant Staphylococcus aureus (MRSA) infections].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Enterocolitis; Female; Humans; Immunocompromised Host; Male; Methicillin Resistance; Middle Aged; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Urinary Bladder Neoplasms; Vancomycin | 1993 |
[Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Dibekacin; Drug Synergism; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Staphylococcus aureus | 1993 |
[Effects of a combination therapy consisting of arbekacin and ampicillin of methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Dibekacin; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1993 |
Synthesis of low-toxicity, 5-deoxy-5-fluoro and 5-deoxy-5,5-difluoro derivatives of arbekacin and its analogs, and study of structure-toxicity relationships.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Deoxy Sugars; Dibekacin; Fluorine; Lethal Dose 50; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Structure-Activity Relationship | 1993 |
Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Inactivation, Metabolic; Magnetic Resonance Spectroscopy; Methicillin Resistance; Staphylococcus aureus | 1993 |
New 2''-amino derivatives of arbekacin, potent aminoglycoside antibiotics against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Structure-Activity Relationship | 1993 |
[Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Coagulase; Dibekacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Methicillin Resistance; Serotyping; Staphylococcal Infections; Staphylococcus aureus | 1993 |
[A study of methicillin-resistant Staphylococcus aureus (MRSA) infection in urological field].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Humans; Immunocompromised Host; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Urologic Diseases; Vancomycin | 1993 |
Synthesis of 5-deoxy-5-epifluoro derivatives of arbekacin, amikacin, and 1-N-[(S)-4-amino-2-hydroxybutanoyl]tobramycin (study on structure--toxicity relationships).
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Carbohydrate Conformation; Carbohydrate Sequence; Dibekacin; Fluorine Compounds; Mice; Molecular Sequence Data; Tobramycin | 1995 |
Enzymatic 2'-N-acetylation of arbekacin and antibiotic activity of its product.
Topics: Acetylation; Acetyltransferases; Acylation; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Microbial Sensitivity Tests; Molecular Structure; Streptomyces; Structure-Activity Relationship | 1996 |
[Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1997 |
Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Dose-Response Relationship, Drug; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1997 |
MRSA meningitis and intrathecal injection of arbekacin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Female; Humans; Injections, Spinal; Meningitis, Bacterial; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus | 1997 |
Investigation of nosocomial infection caused by arbekacin-resistant, methicillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Methicillin Resistance; Middle Aged; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus | 1997 |
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Humans; Infant; Male; Methicillin Resistance; Microbial Sensitivity Tests; Pulmonary Atresia; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin; Wounds and Injuries | 1997 |
Antibiotic-loaded hydroxyapatite blocks in the treatment of experimental osteomyelitis in rats.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Dibekacin; Drug Delivery Systems; Drug Implants; Hydroxyapatites; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia | 1997 |
Blepharismin produced by a protozoan Blepharisma functions as an antibiotic effective against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Ciliophora; Dibekacin; Drug Synergism; Methicillin Resistance; Perylene; Photochemistry; Pigments, Biological; Staphylococcus aureus | 1997 |
[The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefozopran; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Vancomycin | 1997 |
A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Kanamycin Kinase; Magnetic Resonance Spectroscopy; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1998 |
Synthesis of 1-N-[(2S,4S)- and (2S,4R)-5-amino-4-fluoro-2-hydroxypentanoyl]dibekacins (study on structure-toxicity relationships).
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbohydrate Sequence; Dibekacin; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 1998 |
[An epidemiological investigation for MRSA and PRSP in Kinki area. Kinki Infection Working Group].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Haemophilus influenzae; Humans; Japan; Methicillin Resistance; Penicillin Resistance; Pseudomonas aeruginosa; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1998 |
The novel enzymatic 3''-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of Streptomyces origin and the resulting activity.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Microbial Sensitivity Tests; Molecular Structure | 1998 |
Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Methicillin; Methicillin Resistance; Penicillins; Staphylococcus aureus | 1998 |
In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 1998 |
Treatment of osteomyelitis by antibiotic impregnated porous hydroxyapatite block.
Topics: Adolescent; Alcaligenes; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Delivery Systems; Durapatite; Female; Hip Prosthesis; Humans; Male; Middle Aged; Osteomyelitis; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus epidermidis; Tuberculosis | 1994 |
Effects of arbekacin and vancomycin on release of lactate dehydrogenase and fragmentation of DNA in LLC-PK1 kidney epithelial cells.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cisplatin; Dibekacin; DNA Damage; DNA Fragmentation; Kidney Tubules; L-Lactate Dehydrogenase; LLC-PK1 Cells; Necrosis; Swine; Vancomycin | 1999 |
[Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].
Topics: Acetyltransferases; Adenosine; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Genes, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Staphylococcus aureus | 1999 |
[Neuromuscular blocking properties of arbekacin, astromicin, isepamicin and netilmicin in the rabbit].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Dose-Response Relationship, Drug; Gentamicins; Netilmicin; Neuromuscular Blocking Agents; Rabbits; Tubocurarine | 1999 |
Role of aminoglycoside 6'-acetyltransferase in a novel multiple aminoglycoside resistance of an actinomycete strain #8: inactivation of aminoglycosides with 6'-amino group except arbekacin and neomycin.
Topics: Acetylation; Acetyltransferases; Actinomycetales; Aminoglycosides; Anti-Bacterial Agents; Cloning, Molecular; Dibekacin; Drug Resistance, Multiple; Neomycin; Streptomyces; Structure-Activity Relationship | 1999 |
[Reliability of disc-diffusion susceptibility testing for arbekacin, vancomycin and teicoplanin against methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus aureus; Teicoplanin; Vancomycin | 1999 |
Methicillin-resistant Staphylococcus aureus (MRSA) isolated at Fukuoka University Hospital and hospitals and clinics in the Fukuoka city area.
Topics: Ambulatory Care Facilities; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cluster Analysis; Coagulase; Dibekacin; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Phylogeny; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Dibekacin; DNA, Bacterial; Drug Interactions; Drug Resistance, Multiple; Drug Therapy, Combination; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sensitivity and Specificity; Staphylococcus aureus; Vancomycin | 2000 |
[Two cases of methicillin-resistant Staphylococcus aureus (MRSA) sepsis following craniotomy].
Topics: Adult; Aged; Alanine; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Craniotomy; Dibekacin; Drug Therapy, Combination; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Methicillin Resistance; Postoperative Complications; Sepsis; Staphylococcal Infections; Sulbactam; Thienamycins; Treatment Outcome; Vancomycin | 2000 |
[Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Vancomycin | 2000 |
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
Topics: Aminoglycosides; Ampicillin; Animals; Anti-Bacterial Agents; Dibekacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rabbits; Treatment Outcome | 2000 |
[Colony PCR for rapid detection of antibiotic resistance genes in MRSA and enterococci].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Enterococcus; Genes, Bacterial; Methicillin Resistance; Polymerase Chain Reaction; Staphylococcus aureus | 2000 |
In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Dibekacin; DNA, Bacterial; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Streptomycin; Vancomycin | 2000 |
Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus | 2000 |
[Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Cephalosporins; Dibekacin; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2001 |
In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals.
Topics: Aminoglycosides; Anti-Bacterial Agents; Brazil; Dibekacin; Drug Resistance, Microbial; Hospitals; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 2001 |
[Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Blood; Culture Media; Depression, Chemical; Dibekacin; Dose-Response Relationship, Drug; Enterotoxins; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Teicoplanin; Vancomycin | 2001 |
Neuromuscular blocking effects of the aminoglycoside antibiotics arbekacin, astromicin, isepamicin and netilmicin on the diaphragm and limb muscles in the rabbit.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Diaphragm; Dibekacin; Dose-Response Relationship, Drug; Gentamicins; In Vitro Techniques; Male; Muscle Contraction; Muscle, Skeletal; Netilmicin; Neuromuscular Junction; Rabbits | 2001 |
[Arbekacin resistant gene, aacA/aphD, in Staphylococcus aureus is lost during in vitro passage].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Genes, Bacterial; Methicillin Resistance; Staphylococcus aureus | 2002 |
Mechanical properties of the femur after injection of calcium phosphate cement containing arbekacin sulfate and polylactic acid in a rat model of experimental osteoporosis.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Calcium Phosphates; Dibekacin; Disease Models, Animal; Drug Delivery Systems; Female; Femur; Lactic Acid; Osteoporosis; Polyesters; Polymers; Rats; Rats, Sprague-Dawley; Stress, Mechanical | 2002 |
Integration analysis of pSK41 in the chromosome of a methicillin-resistant Staphylococcus aureus K-1.
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Bleomycin; Chromosomes, Bacterial; Conjugation, Genetic; Dibekacin; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Deletion; Gene Expression Regulation, Bacterial; Humans; Methicillin Resistance; Molecular Sequence Data; Plasmids; Restriction Mapping; Sequence Analysis, DNA; Staphylococcus aureus; Transcription, Genetic | 2002 |
Contact dermatitis from arbekacin sulfate: report of a case.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Dermatitis, Allergic Contact; Dibekacin; Female; Humans; Skin | 2002 |
Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Eye Infections, Bacterial; Female; Humans; Incidence; Keratitis; Male; Methicillin; Methicillin Resistance; Middle Aged; Ofloxacin; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2002 |
Treatment outcome of two-stage revision total hip arthroplasty for infected hip arthroplasty using antibiotic-impregnated cement spacer.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Cements; Dibekacin; Female; Gentamicins; Hip Prosthesis; Humans; Male; Middle Aged; Prosthesis-Related Infections; Reoperation; Treatment Outcome | 2003 |
[Survey of susceptibility of methicillin-resistant Staphylococcus aureus to antimicrobial agents in Hokusetsu General Hospital].
Topics: Aminoglycosides; Anti-Bacterial Agents; Coagulase; Dibekacin; Drug Resistance, Bacterial; Hospitals, General; Japan; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Teicoplanin; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2002 |
Pharmacokinetics and dosing of arbekacin in preterm and term newborn infants.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Gentamicins; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature | 2003 |
[Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Methicillin Resistance; Phosphotransferases (Alcohol Group Acceptor); Staphylococcus aureus | 2003 |
[Attenuation of arbekacin-induced nephrotoxicity in rats by pazufloxacin mesilate].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dibekacin; Drug Interactions; Drug Therapy, Combination; Fluoroquinolones; Kidney Cortex; Kidney Diseases; Kidney Tubules; Male; Oxazines; Rats; Rats, Sprague-Dawley | 2003 |
Arbekacin is actively secreted in the rat intestine via a different efflux system from P-glycoprotein.
Topics: Aminoglycosides; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Dibekacin; Humans; In Vitro Techniques; Intestine, Small; Male; Rats; Rats, Wistar; Swine | 2003 |
Efficacy and safety of arbekacin for staphylococcal infection in the NICU.
Topics: Aminoglycosides; Anti-Bacterial Agents; Creatinine; Cross Infection; Dibekacin; Evoked Potentials, Auditory, Brain Stem; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Methicillin Resistance; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Molecular mechanism for the enhancement of arbekacin resistance in a methicillin-resistant Staphylococcus aureus.
Topics: Acetylation; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Blotting, Northern; Catalysis; Dibekacin; DNA Primers; DNA, Bacterial; Genes, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Phosphorylation; Promoter Regions, Genetic; Sequence Homology, Nucleic Acid; Staphylococcus aureus | 2003 |
Application of artificial neural network modelling to identify severely ill patients whose aminoglycoside concentrations are likely to fall below therapeutic concentrations.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Artificial Intelligence; Dibekacin; Humans; Intensive Care Units; Logistic Models; Neural Networks, Computer; Predictive Value of Tests; Reference Values; Severity of Illness Index | 2003 |
Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Blood Coagulation; Colony Count, Microbial; Dibekacin; Drug Therapy, Combination; Endocarditis, Bacterial; Fibrin; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides.
Topics: Aged; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Cloning, Molecular; Dibekacin; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Histidine; Humans; Male; Methylation; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Ribosomes; RNA, Ribosomal, 16S; Serratia Infections; Serratia marcescens; tRNA Methyltransferases | 2004 |
[Epidemiological study of Arbekacin-resistant, methicillin resistant Staphylococcus aureus in Saitama Medical School Hospital].
Topics: Aminoglycosides; Cross Infection; Dibekacin; Drug Resistance, Bacterial; Epidemiologic Studies; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 2004 |
[Sensitivity of MRSA isolated in our hospital to various antibacterial agents: changes over 5 years].
Topics: Aminoglycosides; Coagulase; Dibekacin; Drug Resistance, Bacterial; Enterotoxins; Humans; Imipenem; Methicillin Resistance; Netilmicin; Ofloxacin; Staphylococcus aureus; Teicoplanin; Vancomycin | 2004 |
[Combined effects of arbekacin with biapenem against in vitro and in vivo model of a mixture of MRSA and Pseudomonas aeruginosa].
Topics: Aminoglycosides; Animals; Anti-Infective Agents; Dibekacin; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Thienamycins | 2004 |
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline.
Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Minocycline; Probability; Sampling Studies; Sensitivity and Specificity; Staphylococcus; Tigecycline; Vancomycin | 2004 |
Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Biofilms; Dibekacin; Disease Models, Animal; Drug Synergism; Fosfomycin; Granuloma; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus | 2005 |
Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance.
Topics: Amino Acid Sequence; Aminoglycosides; Dibekacin; Drug Resistance, Bacterial; Humans; Methicillin Resistance; Molecular Sequence Data; Phosphorylation; RNA, Messenger; Staphylococcus aureus; Substrate Specificity | 2004 |
Dosage regimen of arbekacin for methicillin-resistant Staphylococcus aureus infection in newborns and infants.
Topics: Aminoglycosides; Biological Availability; Birth Weight; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Maximum Tolerated Dose; Methicillin Resistance; Prospective Studies; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2004 |
[Combination effect of pazufloxacin and anti-mrsa drugs against beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)].
Topics: Aminoglycosides; beta-Lactams; Dibekacin; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; In Vitro Techniques; Methicillin Resistance; Minocycline; Oxazines; Staphylococcus aureus; Teicoplanin; Vancomycin Resistance | 2005 |
Global spread of multiple aminoglycoside resistance genes.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Dibekacin; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methyltransferases; Microbial Sensitivity Tests; RNA, Ribosomal, 16S | 2005 |
Effect of arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Biofilms; Dibekacin; Disease Models, Animal; Granuloma; Humans; Male; Methicillin Resistance; Microscopy, Electron, Scanning; Necrosis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2004 |
Synergistic effect of [10]-gingerol and aminoglycosides against vancomycin-resistant enterococci (VRE).
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Catechols; Cell Count; Colony Count, Microbial; Detergents; Dibekacin; Drug Synergism; Enterococcus faecalis; Fatty Alcohols; Microbial Sensitivity Tests; Mutagens; Phosphotransferases (Alcohol Group Acceptor); Sodium Dodecyl Sulfate; Structure-Activity Relationship; Surface-Active Agents; Vancomycin Resistance | 2006 |
Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Enterococcus faecalis; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline | 2006 |
Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Drug Synergism; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Teicoplanin; Vancomycin; Virginiamycin | 2006 |
Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000).
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Coagulase; Deoxyribonucleases, Type II Site-Specific; Dibekacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enzymes; Hospitals; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Staphylococcal Infections; Staphylococcus aureus | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Population pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Dose-Response Relationship, Drug; Female; Humans; Male; Methicillin Resistance; Middle Aged; Models, Statistical; Population; Reproducibility of Results; Sepsis; Staphylococcal Infections | 2006 |
Usefulness of PCR-restriction fragment length polymorphism typing of the coagulase gene to discriminate arbekacin-resistant methicillin-resistant Staphylococcus aureus strains.
Topics: Aminoglycosides; Anti-Infective Agents; Bacterial Typing Techniques; Coagulase; Dibekacin; Drug Resistance, Bacterial; Humans; Methicillin Resistance; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method.
Topics: Amikacin; Aminoglycosides; Antitubercular Agents; Colony Count, Microbial; Dibekacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Japan; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Mycobacterium tuberculosis; Nocardia asteroides; Nontuberculous Mycobacteria; Prevalence; Streptomycin; Tobramycin | 2006 |
[Appropriate use of anti-MRSA drugs (discussion)].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Dibekacin; Humans; Immunocompromised Host; Linezolid; Methicillin Resistance; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Hospitals, Convalescent; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Tokyo | 2007 |
Synthesis and antibacterial activity of 5-deoxy-5-episubstituted arbekacin derivatives.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Chemistry, Pharmaceutical; Dibekacin; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Models, Chemical; Pseudomonas aeruginosa; Staphylococcus aureus | 2007 |
16S rRNA methylase-producing, gram-negative pathogens, Japan.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Japan; Methyltransferases; Microbial Sensitivity Tests; RNA, Ribosomal, 16S | 2007 |
Effect of varying the 4''-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Dibekacin; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Staphylococcus aureus | 2007 |
Microbiological and clinical study of methicillin-resistant Staphylococcus aureus (MRSA) carrying VraS mutation: changes in susceptibility to glycopeptides and clinical significance.
Topics: Aged; Amino Acid Substitution; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Dibekacin; Female; Glycopeptides; Humans; Imipenem; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Mutation; Oxacillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Prediction of aminoglycoside response against methicillin-resistant Staphylococcus aureus infection in burn patients by artificial neural network modeling.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Blood Glucose; Burns; Creatinine; Dibekacin; Female; Forecasting; Humans; Logistic Models; Male; Methicillin Resistance; Middle Aged; Neural Networks, Computer; Retrospective Studies; Severity of Illness Index; Skin Transplantation; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2008 |
[In vitro activity of arbekacin against clinical isolates of Staphylococcus species and gram-negative bacilli].
Topics: Anti-Bacterial Agents; Dibekacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2007 |
[Analysis of factors in selecting anti-methicillin-resistant Staphylococcus aureus drugs by doctors].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Humans; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2008 |
Influences of dosage regimen and co-administration of low-molecular weight proteins and basic peptides on renal accumulation of arbekacin in mice.
Topics: Aminoglycosides; Animals; Dibekacin; Dose-Response Relationship, Drug; Kidney; Male; Mice; Molecular Weight; Peptides; Proteins | 2008 |
Population pharmacokinetics of arbekacin in burn patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Burns; Dibekacin; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Retrospective Studies | 2008 |
Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Creatinine; Cystatin C; Cystatins; Dibekacin; Drug Monitoring; Female; Glomerular Filtration Rate; Hospitals, University; Humans; Male; Methicillin Resistance; Renal Insufficiency; Staphylococcal Infections | 2008 |
[Appropriate use of anti-methicillin-resistant Staphylococcus aureus agents in a retrospective study].
Topics: Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Drug Resistance, Bacterial; Humans; Methicillin Resistance; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2008 |
[Analysis of factors affecting long-term administration of anti-methicillin resistant Staphylococcus aureus (MRSA) drugs].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dibekacin; Humans; Immunosuppressive Agents; Methicillin Resistance; Multivariate Analysis; Serum Albumin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2009 |
[Case with large abdominal abscess associated with a ventriculoperitoneal shunt].
Topics: Abdominal Abscess; Anti-Bacterial Agents; Brain Abscess; Child; Dibekacin; Drainage; Female; Humans; Immunocompromised Host; Staphylococcal Infections; Vancomycin; Ventriculoperitoneal Shunt | 2009 |
Effect of PEGylation of N-WASP181-200 on the inhibitory potency for renal aminoglycoside accumulation.
Topics: Animals; Anti-Bacterial Agents; Dibekacin; Gentamicins; Kidney; Male; Mice; Mice, Inbred Strains; Peptide Fragments; Polyethylene Glycols; Protein Conformation; Rats; Rats, Wistar; Wiskott-Aldrich Syndrome Protein, Neuronal | 2009 |
MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy.
Topics: Abscess; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Dibekacin; Fever; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pyomyositis; Remission Induction; Staphylococcal Infections | 2009 |
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2009 |
Pharmacokinetics and pharmacodynamics of once-daily arbekacin during continuous venovenous hemodiafiltration in critically ill patients.
Topics: Aged; Anti-Infective Agents; Computer Simulation; Critical Illness; Dibekacin; Drug Administration Schedule; Hemofiltration; Humans; Microbial Sensitivity Tests; Middle Aged | 2009 |
Biological activities of pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.
Topics: Actinomycetales; Anti-Bacterial Agents; Cell Membrane; Dibekacin; Enterococcus faecalis; Fluorescent Dyes; Membrane Potentials; Microbial Sensitivity Tests; Novobiocin; Peptides, Cyclic; Staphylococcus aureus; Vancomycin | 2010 |
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare | 2010 |
Staphylococcal scalded skin syndrome in an extremely low-birth-weight neonate: molecular characterization and rapid detection by multiplex and real-time PCR of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Dibekacin; Humans; Immunoglobulin G; Immunologic Factors; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Methicillin-Resistant Staphylococcus aureus; Polymerase Chain Reaction; Staphylococcal Scalded Skin Syndrome | 2011 |
Mycobacterium abscessus corneal ulcer following sutured clear corneal cataract incision.
Topics: Anti-Infective Agents; Cataract Extraction; Cornea; Corneal Ulcer; Dibekacin; DNA, Bacterial; Eye Infections, Bacterial; Female; Humans; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Surgical Wound Infection; Suture Techniques | 2010 |
Perioperative antimicrobials in chest surgery patients positive for methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Dibekacin; Drug Administration Schedule; Guideline Adherence; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Perioperative Care; Practice Guidelines as Topic; Pulmonary Surgical Procedures; Staphylococcal Infections; Surgical Wound Infection; Time Factors; Treatment Outcome; Vancomycin | 2010 |
[Evaluation of once a day of arbekacin administration to neonates as a new object of peak concentration].
Topics: Anti-Infective Agents; Dibekacin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2010 |
Clinical efficacy of arbekacin for Gram-negative bacteria.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coinfection; Dibekacin; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections | 2011 |
[Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Cefazolin; Ciprofloxacin; Dibekacin; Drug Resistance, Bacterial; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Thienamycins; Vancomycin | 2011 |
The usefulness of arbekacin compared to vancomycin.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Dibekacin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2012 |
In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in Japan.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Dibekacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Statistics, Nonparametric | 2012 |
Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA.
Topics: Adult; Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Endocarditis; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Intrathoracic irrigation with arbekacin for methicillin-resistant Staphylococcus aureus empyema following lung resection.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Empyema, Pleural; Female; Follow-Up Studies; Humans; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonectomy; Postoperative Complications; Retrospective Studies; Staphylococcal Infections; Therapeutic Irrigation; Thoracic Cavity; Treatment Outcome | 2012 |
Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6')/APH(2″).
Topics: Acetyltransferases; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Enzyme Inhibitors; Furans; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Phosphotransferases (Alcohol Group Acceptor) | 2012 |
novel 6'-n-aminoglycoside acetyltransferase AAC(6')-Iaj from a clinical isolate of Pseudomonas aeruginosa.
Topics: Acetylation; Acetyltransferases; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Chromatography, Thin Layer; Dibekacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gentamicins; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Substrate Specificity | 2013 |
[Arbekacin sulfate concentrations in peripheral lymph and in serum after intravenous injection: report of four cases].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Female; Humans; Injections, Intravenous; Lymph; Male; Middle Aged | 2012 |
Evaluation of arbekacin anti-MRSA agents for adult in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; C-Reactive Protein; Dibekacin; Female; Humans; Leukocyte Count; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged | 2012 |
[Clinical investigation of arbekacin sulfate based on Cmax/MIC].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Dibekacin; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal | 2012 |
Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Japan; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Sepsis | 2013 |
Rapid quantification of the aminoglycoside arbekacin in serum using high performance liquid chromatography-tandem mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Dibekacin; Humans; Tandem Mass Spectrometry | 2013 |
Emergence of Staphylococcus aureus carrying multiple drug resistance genes on a plasmid encoding exfoliative toxin B.
Topics: Anti-Bacterial Agents; Base Sequence; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Exfoliatins; Gentamicins; Humans; Impetigo; Japan; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Retrospective Studies; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus | 2013 |
Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
Topics: Anti-Infective Agents; Consensus; Dibekacin; Drug Monitoring; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2014 |
Nosocomial spread of meticillin-resistant Staphylococcus aureus with β-lactam-inducible arbekacin resistance.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dibekacin; DNA Transposable Elements; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Molecular Sequence Data; Molecular Typing; Sequence Analysis, DNA; Staphylococcal Infections; Transcriptional Activation | 2014 |
Pharmacokinetics of arbekacin in bronchial epithelial lining fluid of healthy volunteers.
Topics: Adult; Anti-Infective Agents; Bronchi; Bronchoalveolar Lavage Fluid; Dibekacin; Epithelium; Female; Healthy Volunteers; Humans; Male; Respiratory Mucosa; Young Adult | 2014 |
Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study.
Topics: Acinetobacter; Anti-Bacterial Agents; Cephamycins; Dibekacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Klebsiella; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Thienamycins | 2014 |
Identification of a novel 6'-N-aminoglycoside acetyltransferase, AAC(6')-Iak, from a multidrug-resistant clinical isolate of Stenotrophomonas maltophilia.
Topics: Acetyltransferases; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Neomycin; Netilmicin; Sisomicin; Stenotrophomonas maltophilia; Tobramycin | 2014 |
[In vitro combined effects of double antibacterial drugs against multidrug-resistant Pseudomonas aeruginosa isolates: comparison among combinations of colistin, arbekacin, aztreonam, rifampicin and piperacillin].
Topics: Anti-Bacterial Agents; Aztreonam; Colistin; Dibekacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Rifampin | 2014 |
[Evaluation of six cases of arbekacin inhalation for pneumonia].
Topics: Adult; Aged; Anti-Bacterial Agents; Child; Dibekacin; Female; Humans; Infant; Male; Pneumonia | 2014 |
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia.
Topics: Amikacin; Anti-Bacterial Agents; Dibekacin; Enterobacter; Humans; Klebsiella; Microbial Sensitivity Tests; Pneumonia; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2015 |
Synthesis and antibacterial activity of 4″ or 6″-alkanoylamino derivatives of arbekacin.
Topics: Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus | 2015 |
External ocular infections due to methicillin-resistant Staphylococcus aureus and medical history.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Conjunctivitis; Cross-Sectional Studies; Dacryocystitis; Dibekacin; Eye Infections, Bacterial; Female; Humans; Infant; Keratitis, Herpetic; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2015 |
Detecting 16S rRNA Methyltransferases in Enterobacteriaceae by Use of Arbekacin.
Topics: Anti-Infective Agents; Dibekacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Genotype; Humans; Phenotype; RNA, Ribosomal, 16S; tRNA Methyltransferases | 2016 |
Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cross Infection; Daptomycin; Dibekacin; Exotoxins; Humans; Japan; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Open Reading Frames; Recombinases; Secondary Care Centers; Skin; Soft Tissue Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Population pharmacokinetics of arbekacin in different infectious disease settings and evaluation of dosing regimens.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Dibekacin; Dose-Response Relationship, Drug; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Models, Biological; Retrospective Studies; Staphylococcal Infections; Young Adult | 2016 |
Paraphaeosphaeride D and berkleasmin F, new circumventors of arbekacin resistance in MRSA, produced by Paraphaeosphaeria sp. TR-022.
Topics: Anti-Bacterial Agents; Ascomycota; Dibekacin; Drug Resistance, Bacterial; Lactams; Magnetic Resonance Spectroscopy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrones; Sesquiterpenes | 2016 |
Efficacy and pharmacokinetics of ME1100, a novel optimized formulation of arbekacin for inhalation, compared with amikacin in a murine model of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Dibekacin; Disease Models, Animal; Drug Compounding; Lung; Mice; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
First Case of Skin and Soft Tissue Infection Caused by Mycoplasma hominis in a Pediatric Immunocompromised Patient.
Topics: Adolescent; Anti-Bacterial Agents; Dibekacin; DNA, Bacterial; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Mycoplasma hominis; Mycoplasma Infections; Polymerase Chain Reaction; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tigecycline; Transplantation, Homologous | 2017 |
Emergence of ArmA, a 16S rRNA methylase in highly aminoglycoside-resistant clinical isolates of Klebsiella pneumoniae and Klebsiella oxytoca in Okinawa, Japan.
Topics: Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Female; Humans; Japan; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Whole Genome Sequencing | 2018 |
An Isolated Method and Assignment for Critical Impurities in Semi-Synthetic Process of Arbekacin Sulfate.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dibekacin; Drug Contamination | 2019 |
Increased Arbekacin Clearance in Patients With Febrile Neutropenia.
Topics: Adult; Aged; Anti-Infective Agents; Cohort Studies; Dibekacin; Drug Monitoring; Febrile Neutropenia; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Retrospective Studies | 2020 |
Arbekacin - A Novel Antibiotic for Critical Infections.
Topics: Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Humans; India; Japan; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2019 |
In vitro activity of arbekacin against multidrug-resistant gram-negative bacilli.
Topics: Anti-Bacterial Agents; Dibekacin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 2021 |
Mechanistic insights into translation inhibition by aminoglycoside antibiotic arbekacin.
Topics: Anti-Bacterial Agents; Dibekacin; Kinetics; Peptide Elongation Factor G; Peptide Termination Factors; Peptides; Protein Biosynthesis; Protein Synthesis Inhibitors; Ribosomes; RNA, Messenger; RNA, Transfer, Amino Acyl | 2021 |
A study of trends and factors associated with therapeutic drug monitoring (TDM) implementation for arbekacin treatment using a large Japanese medical claims database.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Humans; Japan; Methicillin-Resistant Staphylococcus aureus | 2022 |
Analysis of impurity profiling of arbekacin sulfate by ion-pair liquid chromatography coupled with pulsed electrochemical detection and online ion suppressor-ion trap-time off light mass spectrometry.
Topics: Amines; Ammonia; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dibekacin; Drug Contamination; Mass Spectrometry; Sodium Hydroxide; Sulfates; Trifluoroacetic Acid | 2022 |